Everton Cazzo1, José Carlos Pareja2, Bruno Geloneze3, Elinton Adami Chaim2, Maria Rita Lazzarini Barreto2, Daniéla Oliveira Magro2. 1. Department of Surgery, Faculty of Medical Sciences, State University of Campinas (UNICAMP), R. Alexander Fleming, s/n; Cidade Universitaria Zeferino Vaz; CEP 13085-000, Campinas, SP, Brazil. notrevezzo@yahoo.com.br. 2. Department of Surgery, Faculty of Medical Sciences, State University of Campinas (UNICAMP), R. Alexander Fleming, s/n; Cidade Universitaria Zeferino Vaz; CEP 13085-000, Campinas, SP, Brazil. 3. Research Laboratory of Metabolism and Diabetes (LIMED), Gastrocentro, State University of Campinas (UNICAMP), Campinas, Brazil.
Abstract
BACKGROUND: Bariatric surgery usually leads to improvement on the general lipid profile, but its role in the levels of apolipoprotein A-IV (Apo-AIV) is not completely understood. Apo-AIV is a gut-released lipoprotein which is enrolled in satiety regulation and presents anti-inflammatory, anti-atherogenic, and anti-oxidative properties. The objective of this study was to determine the influence of biliopancreatic diversion (BPD) in the levels of Apo-AIV. METHODS: This is a prospective exploratory study which evaluated eight obese individuals with type 2 diabetes mellitus (T2DM) who underwent BPD (Scopinaro operation) and were followed-up for 12 months. Apo-AIV levels were determined by means of serial dosages through a standard meal tolerance test (MTT) in the immediate preoperative period and then 12 months later. RESULTS: There was a significant change in the Apo-AIV curve following MTT before and after surgery. At 0 and 45 min, the Apo-AIV levels did not significantly differ before and after surgery; at 120 and 180 min, Apo-AIV levels were significantly lower following BPD. CONCLUSIONS: We observed a decrease of postprandial levels of Apo-AIV following MTT in mildly obese individuals with T2DM. This finding appears to be related to the suppression in the Apo-AIV response that obese individuals tend to present. Weight reduction itself, endotoxemia, and the large segments of bypassed intestine may be enrolled in this impaired response.
BACKGROUND: Bariatric surgery usually leads to improvement on the general lipid profile, but its role in the levels of apolipoprotein A-IV (Apo-AIV) is not completely understood. Apo-AIV is a gut-released lipoprotein which is enrolled in satiety regulation and presents anti-inflammatory, anti-atherogenic, and anti-oxidative properties. The objective of this study was to determine the influence of biliopancreatic diversion (BPD) in the levels of Apo-AIV. METHODS: This is a prospective exploratory study which evaluated eight obese individuals with type 2 diabetes mellitus (T2DM) who underwent BPD (Scopinaro operation) and were followed-up for 12 months. Apo-AIV levels were determined by means of serial dosages through a standard meal tolerance test (MTT) in the immediate preoperative period and then 12 months later. RESULTS: There was a significant change in the Apo-AIV curve following MTT before and after surgery. At 0 and 45 min, the Apo-AIV levels did not significantly differ before and after surgery; at 120 and 180 min, Apo-AIV levels were significantly lower following BPD. CONCLUSIONS: We observed a decrease of postprandial levels of Apo-AIV following MTT in mildly obese individuals with T2DM. This finding appears to be related to the suppression in the Apo-AIV response that obese individuals tend to present. Weight reduction itself, endotoxemia, and the large segments of bypassed intestine may be enrolled in this impaired response.
Authors: Ali Aminian; Andrea Zelisko; John P Kirwan; Stacy A Brethauer; Philip R Schauer Journal: Surg Obes Relat Dis Date: 2014-08-11 Impact factor: 4.734
Authors: M T García-Unzueta; R Fernández-Santiago; A Domínguez-Díez; L Vazquez-Salví; J C Fernández-Escalante; J A Amado Journal: Obes Surg Date: 2005-02 Impact factor: 4.129
Authors: D Benaiges; J A Flores-Le-Roux; J Pedro-Botet; J M Ramon; A Parri; M Villatoro; M J Carrera; M Pera; E Sagarra; L Grande; A Goday Journal: Obes Surg Date: 2012-08 Impact factor: 4.129
Authors: Magdalena Vila; Olga Ruíz; Mar Belmonte; Maria Riesco; Antonia Barceló; Gerardo Perez; Jose Moreiro; Ramon Salinas Journal: Obes Surg Date: 2009-01-06 Impact factor: 4.129
Authors: N Dib; A Kiciak; P Pietrzak; K Ferenc; P Jaworski; M Kapica; W Tarnowski; R Zabielski Journal: J Physiol Pharmacol Date: 2013-10 Impact factor: 3.011
Authors: John E Farey; Tamara C Preda; Oliver M Fisher; Angelique J Levert-Mignon; Rebecca L Stewart; Elisabeth Karsten; Benjamin R Herbert; Michael M Swarbrick; Reginald V Lord Journal: Obes Surg Date: 2017-02 Impact factor: 4.129